| 1. |
Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum cal-cium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study[J]. Kidney Int, 2006, 70(2): 351-357.
|
| 2. |
张建荣，张凌. 慢性肾脏病继发性甲旁亢[M]. 北京: 人民军医出版社，2010: 85-92.
|
| 3. |
Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis[J]. JAMA, 2011, 305(11): 1119-1127.
|
| 4. |
张凌. 重视慢性肾衰竭患者高磷血症的处理[J]. 中国血液净化，2004，3 (4)：181-183.
|
| 5. |
Block GA, Spiegel DM, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to henodialysis[J]. Kidney Int, 2005, 68(4): 1815-1824.
|
| 6. |
Sprague SM, Abboud H, Qin P, et al. Lanthanum carbonate reduces phosphorus burder in patients with CKD stage 3 and 4: a randomized trial[J]. Clin J Am Soc Nephrol, 2009, 4(1): 178-185.
|
| 7. |
尹道馨，张东亮，刘文虎. 血液透析滤过在维持性透析患者中的临床应用[J].首都医科大学学报，2009, 30(2): 154-160.
|
| 8. |
Davenport A, Gardner C, Delaney M, et al. The effect of dialysis modality on phosphate control: haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit[J]. Nephrol Dial Transplant, 2010, 25(3): 897-901.
|
| 9. |
王秀玲, 刘健, 桑小红, 等．HA型大孔树脂血液灌流治疗慢性肾功能衰竭的临床观察[J]. 中华肾脏病杂志, 2000, 16(2): 97-99.
|
| 10. |
唐万欣，陶冶，付平，等. 连续性静脉-静脉血液滤过中低磷血症防治及危重评分相关性研究[J]. 华西医学, 2007, 22(1): 40-41.
|
| 11. |
张景红, 宦红娣. 维持性血液透析患者高磷血症的控制[J]. 中国血液净化, 2009, 8(10): 533-535.
|
| 12. |
李海明, 顾勇, 薛骏，等. 甲状旁腺全切除加前臂移植治疗尿毒症继发性甲状旁腺功能亢进[J]. 中华肾脏病杂志, 2006,22(4): 197-200.
|
